1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P5275
    Tripeptide-41 Inducer 99.63%
    Tripeptide-41(CG-Lipoxyn) 是一种具有减少脂肪堆积作用的生物活性肽,已被报道用作化妆品成分。
    Tripeptide-41
  • HY-N4327
    Eurycomalactone

    东革内酯

    Inhibitor 98.99%
    Eurycomalactone 是一种可以从 Eurycoma longifolia Jack 中分离得到的活性拟松类化合物。Eurycomalactone 是一种有效的NF-κB 抑制剂,其 IC50 值为 0.5 μM。Eurycomalactone 可抑制蛋白合成,降低 cyclin D1 蛋白水平。Eurycomalactone 通过阻滞细胞周期于G2/M 期和延迟 DNA 双链断裂修复来提高放射敏感性。Eurycomalactone 抑制 AKT/NF-κB 信号通路的激活,诱导细胞凋亡并增强对 Cisplatin (HY-17394) 的化疗敏感性。
    Eurycomalactone
  • HY-B0185G
    Lidocaine (GMP) Inhibitor
    Lidocaine (GMP) 是 GMP 级别的 Lidocaine (HY-B0185)。GMP 级别的小分子可用做细胞疗法中的辅助试剂。Lidocaine 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine 通过调节 miR-145 表达和进一步抑制 MEK/ERKNF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine 是一种酰胺衍生物,可用于研究室性心律失常。
    Lidocaine (GMP)
  • HY-B0185AS
    Lidocaine-d10 hydrochloride

    盐酸利多卡因 d10 (盐酸盐)

    Inhibitor 99.79%
    Lidocaine-d10 (hydrochloride) 是 Lidocaine hydrochloride 的氘代物。Lidocaine (Lignocaine) hydrochloride 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine hydrochloride 通过调节 miR-145 表达和进一步抑制 MEK/ERKNF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine hydrochloride 是一种酰胺衍生物,具有研究室性心律失常的潜力。
    Lidocaine-d<sub>10</sub> hydrochloride
  • HY-100977
    Dimethoxycurcumin Inhibitor 98.89%
    Dimethoxycurcumin 是 curcumin 的衍生物,具有抗炎和抗氧化活性。
    Dimethoxycurcumin
  • HY-N8413
    Chlojaponilactone B Inhibitor ≥98.0%
    Chlojaponilactone B 是一种具有抗炎特性的茚烷型倍半萜类化合物。Chlojaponilactone B 通过抑制 TLR4 并随后减少活性氧 (ROS) 的产生、下调 NF-κB 来抑制炎症反应,从而减少促炎细胞因子 iNOS、NO、COX-2、IL-6 和 TNF-α 的表达。
    Chlojaponilactone B
  • HY-Y1322
    Triphenyl phosphate

    磷酸三苯基酯

    Activator 99.67%
    Triphenyl phosphate 是一种有机磷酸盐阻燃剂。Triphenyl phosphate 可通过激活 MAOA/ROS/NFκB 破坏胎盘色氨酸代谢,诱发异常的神经行为。Triphenyl phosphate 促进核因子 κ B (NFκB)、白细胞介素-6肿瘤坏死因子α 等炎症因子诱导氧化应激。Triphenyl phosphate 可引起过敏性接触性皮炎。
    Triphenyl phosphate
  • HY-121955
    FW1256 Inhibitor
    FW1256 是一种苯基类似物,也是一种缓释硫化氢 (H2S) 供体。FW1256 抑制 NF-κB 活性,并可诱导细胞凋亡 (apoptosis),具有有效的抗炎作用,并可用于癌症和心血管疾病的研究。
    FW1256
  • HY-155765
    Anti-inflammatory agent 51 Inhibitor 98.08%
    Anti-inflammatory agent 51 (compound 11d) 是一种酰胺/磺酰胺衍生物,具有抗炎活性。Anti-inflammatory agent 51 抑制 NF-κB 激活,具有用于急性肺损伤和溃疡性结肠炎研究的潜力。
    Anti-inflammatory agent 51
  • HY-142119S
    5-Hydroxy tryptophol β-D-glucuronide-d4 ≥98.0%
    5-Hydroxy tryptophol β-D-glucuronide-d4 是 5-Hydroxy tryptophol β-D-glucuronide 的氘代物。
    5-Hydroxy tryptophol β-D-glucuronide-d<sub>4</sub>
  • HY-W015883R
    Fumaric acid (Standard)

    反丁烯二酸 (Standard)

    Inhibitor 99.93%
    Fumaric acid (Standard) 是 Fumaric acid 的分析标准品。本产品用于研究及分析应用。Fumaric acid 是一种不饱和二碳酸,是柠檬酸循环的中间产物,以 ATP 的形式提供细胞内能量。Fumaric acid 通过抑制 p38 MAPK 依赖的 NF-κB 信号通路发挥抗炎作用。Fumaric acid 可用于妊娠高血压的研究。
    Fumaric acid (Standard)
  • HY-N8707
    Homobutein Inhibitor 98.35%
    Homobutein 是一种天然查尔酮 (可存在于许多药用植物、水果、蔬菜、香料和坚果中) 和有效的 HDACs/NF-κB 双重抑制剂,其 IC50 值分别为 190 和 38 μM。Homobutein 也是一种铁离子 (II 和 III) 螯合剂,具各种活性,包括抗癌,抗炎,抗寄生虫和抗氧化活性。
    Homobutein
  • HY-N0708R
    Vanillic acid (Standard)

    香草酸 (Standard)

    Inhibitor
    Vanillic acid (Standard) 是 Vanillic acid 的分析标准品。本产品用于研究及分析应用。Vanillic acid 是一种在食用植物和水果中发现的调味剂,在当归根部也可以发现。Vanillic acid 抑制 NF-κB 活化。具有抗炎,抗菌等活性。
    Vanillic acid (Standard)
  • HY-101410R
    SDMA (Standard)

    对称二甲基精氨酸 (Standard)

    Activator
    SDMA (Standard)是 SDMA 的分析标准品。本产品用于研究及分析应用。SDMA (Symmetric dimethylarginine)是一氧化氮 (NO) 合酶活性的内源性抑制剂。SDMA 是一种新的肾脏生物标志物,可以比传统的肌酐检测更早地诊断肾脏疾病。
    SDMA (Standard)
  • HY-W012349
    2′-Hydroxychalcone

    2'-羟基查尔酮

    Inhibitor
    2'-Hydroxychalcone 是查尔酮的羟基衍生物,具有抗癌活性。2'-Hydroxychalcone 抑制 NF-κB 通路并诱导乳腺癌细胞自噬 (autophagy) 和凋亡 (apoptosis)。2′-Hydroxychalcone 对复合副球孢子菌属显示出更好的抗真菌活性。
    2′-Hydroxychalcone
  • HY-B0190B
    Nafamostat hydrochloride

    盐酸萘莫司他

    Nafamostat hydrochloride,一种抗凝剂,是一种人工合成的丝氨酸蛋白酶 (serine protease) 抑制剂。Nafamostat hydrochloride 具有抗癌和抗病毒作用,Nafamostat hydrochloride 通过上调肿瘤坏死因子受体 1 (TNFR1) 的表达诱导凋亡 (apoptosis),可用于动脉壁病理性增厚的发生发展。
    Nafamostat hydrochloride
  • HY-19498
    WAY-204688 Inhibitor 99.89%
    WAY-204688 是雌激素受体 (ER-α) 选择性的,口服活性的 NF-κB 转录活性抑制剂。在 HAECT 细胞中,作用于NF-κB-Luc 荧光素酶,IC50 为 122 ± 30 nM。
    WAY-204688
  • HY-W011474R
    Geranylgeraniol (Standard)

    香叶基香叶醇 (Standard); 基牻牛儿醇 (Standard)

    Inhibitor
    Geranylgeraniol (Standard)是 Geranylgeraniol 的分析标准品。本产品用于研究及分析应用。Geranylgeraniol 是一种口服有效的维生素 K2 亚型,是甲戊酸途径 (mevalonate pathway) 的中间体。Geranylgeraniol 靶向 NF-kB 信号通路,可在动物模型中减轻脂多糖 (LPS) 诱导的小胶质细胞炎症。
    Geranylgeraniol (Standard)
  • HY-117726
    WAY-169916 Inhibitor 99.60%
    WAY-169916 是一种雌激素受体的途径选择性配体,通过抑制 NF-kB 转录活性发挥作用。WAY-169916 具有抗炎活性。
    WAY-169916
  • HY-135317B
    Emavusertib hydrochloride Inhibitor
    Emavusertib hydrochloride (CA-4948 tosylate) 是 Emavusertib (HY-135317) 的盐酸盐形式。Emavusertib hydrochloride 是口服有效的 IRAK4 (IC50=57 nM) 和 FLT3 抑制剂。Emavusertib hydrochloride 可抑制 NF-κBMyD88 信号通路,减少促炎细胞因子(如 IL-6 和 IL-10)的产生,从而表现出抗炎和对癌细胞的抗增殖活性,诱导细胞凋亡 (apoptosis)。Emavusertib hydrochloride 在小鼠模型中表现出抗肿瘤活性。
    Emavusertib hydrochloride
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.